RGT
0.072
105.7%
KLV
0.046
-42.5%
TAT
0.03
76.5%
1TT
0.002
-33.3%
8CO
0.04
66.7%
ARV
0.003
-25%
MOM
0.003
50%
EV1
0.009
-25%
X2M
0.006
50%
AUQ
0.034
-24.4%
PGD
0.16
45.5%
IMU
0.105
-22.2%
CTO
0.013
44.4%
NWM
0.007
-22.2%
AXL
0.084
42.4%
RLF
0.035
-20.5%
KTA
0.007
40%
BPG
0.4
-20%
SKN
0.007
40%
CLU
0.012
-20%
PL3
0.12
33.3%
MQR
0.004
-20%
CCX
0.054
31.7%
RGL
0.008
-20%
ARI
0.025
31.6%
CBE
0.265
-19.7%
CXU
0.115
27.8%
NPM
0.017
-19%
DXN
0.21
27.3%
CYP
0.013
-18.8%
SVY
0.019
26.7%
PKY
0.048
-18.6%
MAY
0.005
25%
C1X
0.11
-18.5%
CLG
0.032
23.1%
TKM
0.11
-18.5%
CKA
0.049
22.5%
MI6
0.62
-18.4%
CPN
0.115
22.3%
OD6
0.115
-17.9%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Control Bionics (ASX:CBL): Expands global reach with exclusive UK and Ireland distribution agreement

Control Bionics (ASX:CBL) expands global reach with exclusive UK and Ireland distribution agreement.

• Exclusive distribution of NeuroNode® by Smart Box in the UK and Ireland.
• Access to Smart Box’s established network of healthcare professionals and end-users.
• Strengthening Control Bionics’ presence in the European market.

Jeremy Steele, CEO of Control Bionics, commented: “The NeuroNode® has already been paired with hundreds of Smart Box
devices and devices with Smart Box software around the world.”

Read the ASX announcement ⚡ https://announcements.asx.com.au/asxpdf/20240909/pdf/067np1hzgg2sbv.pdf